The Valley Desk

NCT04947319 · Interventional trial

Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)

Overall registry status Active not recruiting

Phase 2

Conditions Primary CNS Lymphoma, Refractory Primary Central Nervous System Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov